(Q38010413)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Mathias Bernhardt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marta Galach

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Daniel Novak

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

16 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

published in

Biotechnology Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

810-821

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22589234%20AND%20SRC:MED&resulttype=core&format=json

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Induced pluripotency: history, mechanisms, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Generation of induced pluripotent stem cells in the absence of drug selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Promotion of direct reprogramming by transformation-deficient Myc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Embryonic stem cell-specific microRNAs promote induced pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Regulation of somatic cell reprogramming through inducible mir-302 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Integration of external signaling pathways with the core transcriptional network in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

A high-efficiency system for the generation and study of human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Telomere and telomerase in stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Culture and characterization of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Genomic alterations in cultured human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

High-resolution genomic profiles of human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

The tumorigenicity of diploid and aneuploid human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Recurrent trisomy and Robertsonian translocation of chromosome 14 in murine iPS cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Epigenetic stem cell signature in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Cancer genes hypermethylated in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Myc proteins as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Emerging role of KLF4 in human gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Embryonic stem cell markers expression in cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplasti

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Generation of induced pluripotent stem cells from human cord blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Comparative analysis of germ cell transcription factors in CNS germinoma reveals diagnostic utility of NANOG

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Lin28 promotes transformation and is associated with advanced human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Selective blockade of microRNA processing by Lin28

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

The nuclear receptors SF1 and LRH1 are expressed in endometrial cancer cells and regulate steroidogenic gene transcription by cooperating with AP-1 factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Pediatric malignant germ cell tumors show characteristic transcriptome profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Epithelial to Mesenchymal Transition Tumors: Fallacious or Snail's Pace?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

New insights of epithelial-mesenchymal transition in cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Suppression of induced pluripotent stem cell generation by the p53-p21 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Shotgun proteomics aids discovery of novel protein-coding genes, alternative splicing, and "resurrected" pseudogenes in the mouse genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

The human OCT-4 isoforms differ in their ability to confer self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Oct4 and its pseudogenes confuse stem cell research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Eleven daughters of NANOG

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Human embryonic genes re-expressed in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Oct4 expression is not required for mouse somatic stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Absence of OCT4 expression in somatic tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Oct4A is expressed by a subpopulation of prostate neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

The novel function of OCT4B isoform-265 in genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Oct4 pseudogenes are transcribed in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Nanog transforms NIH3T3 cells and targets cell-type restricted genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Functional evidence that the self-renewal gene NANOG regulates human tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

NANOGP8 is a retrogene expressed in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Rules for making human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Cancer revoked: oncogenes as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Reprogramming of a melanoma genome by nuclear transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Generation of iPSCs from cultured human malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Defined factors induce reprogramming of gastrointestinal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

KLF4 Expression Correlates with the Degree of Differentiation in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

An Argument against a Role for Oct4 in Somatic Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

The Nuclear Receptor Nr5a2 Can Replace Oct4 in the Reprogramming of Murine Somatic Cells to Pluripotent Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347

Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201100347